We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Treating Addiction With Psychedelics: An Interview With Professor David Nutt and Anthony Tennyson, Awakn Life Sciences

Psychedelics are being explored for a myriad of neurological and psychiatric conditions. In this video, Technology Networks speak with Professor David Nutt and Anthony Tennyson from Awakn Life Sciences, a Toronto-based company who focus on the use of psychedelics to treat addiction.

We discussed the unique considerations of treating addiction, the role of psychotherapy in psychedelic treatments and how regulation of psychedelics could change in the near future.